tiprankstipranks

Daniel Mitchell Insider Profile

4 Followers
Daniel Mitchell, Director at GlobeImmune, holds 611.00 shares in Arca Biopharma (Ticker: ABIO), holds 16.76K shares in GlobeImmune (Ticker: GBIM), holds 1.54M shares in Cardiovascular Systems (Ticker: CSII). Most recently, Daniel Mitchell Bought ― shares of Arca Biopharma on May 03, 2017 for an estimated value of 29.81K.
tipranks
Daniel Mitchell

Daniel Mitchell
GlobeImmune (GBIM)
Director

Ranked #1,184 out of 98,743 Corporate Insiders

Profitable Transactions

83%
10 out of 12 Profitable Transactions

Average Return

+54.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3K
71.67%
28.33%
A breakdown of Daniel Mitchell's holdings

Insider Roles

Arca Biopharma
(ABIO)
Director
GlobeImmune
(GBIM)
Director
Roles that Daniel Mitchell holds in companies

Most Profitable Insider Trade

Stock:
GlobeImmune
(GBIM)
Rating:Informative Sell
Date:Feb 23, 2016 - Feb 23, 2017
Return:+89.50%
The most profitable trade made by Daniel Mitchell

Daniel Mitchell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GlobeImmune
Mar 18, 2016
Director
Informative Sell
35.79K
$838.15
Arca Biopharma
May 03, 2017
Director
Informative Buy
29.81K
$2.12K
CSII
Cardiovascular Systems
$30.80M
List of latest transactions for each holding click on a transaction to see Daniel Mitchell's performance on stock

Daniel Mitchell insider profile FAQ

What is the percentage of profitable transactions made by Daniel Mitchell?
The percentage of profitable transactions made by Daniel Mitchell is 83%.
    What is the average return per transaction made by Daniel Mitchell?
    The average return per transaction made by Daniel Mitchell is 54.20%.
      What stocks does Daniel Mitchell hold?
      Daniel Mitchell holds: GBIM, ABIO, CSII stocks.
        What was Daniel Mitchell’s latest transaction?
        Daniel Mitchell latest transaction was an Informative Buy of $29.81K.
          What was Daniel Mitchell's most profitable transaction?
          Daniel Mitchell’s most profitable transaction was an Informative Sell of GBIM stock on February 23, 2016. The return on the trade was 89.50%.
            What is Daniel Mitchell's role in GlobeImmune?
            Daniel Mitchell's role in GlobeImmune is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.